| Ytd | -92.03% | |
| 1y | -95.30% |
| Open | 0.17 | Prev Close | 0.16 | Low | 0.16 | High | 0.17 | Mkt Cap | 3.25M |
| Vol | 245.91K | Avg Vol | 11.60M | EPS | -1.88 | P/E | N/A | Forward P/E | -9.31 |
| Beta | 6.04 | Short Ratio | 0.66 | Inst. Own | 13.72% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-16 | 50-d Avg | 0.30 | 200-d Avg | 1.04 | 1yr Est | 6.30 |
VVOS News
Gainers Modular Medical (NASDAQ:MODD) shares increased by 11.3% to $3.14 during Wednesday's pre
LITTLETON, Colo., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or "the Compa
Gainers bioAffinity Technologies (NASDAQ:BIAF) shares rose 43.1% to $6.53 during Tuesday's regu
Gainers bioAffinity Technologies (NASDAQ:BIAF) shares increased by 68.4% to $7.68 during Tuesday
Littleton, Colorado--(Newsfile Corp. - September 1, 2026) - Vivos Therapeutics, Inc. (NASDAQ: VVOS)
Shares of Pyxis Tankers Inc (NASDAQ:PXS) rose sharply in pre-market trading after the company report
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 300 points on Mond
Gainers Redhill Biopharma (NASDAQ:RDHL) shares increased by 96.7% to $1.3 during Monday's pre-m
Shares of Webuy Global Ltd (NASDAQ:WBUY) rose sharply in pre-market trading. Webuy reported recor
LITTLETON, Colo., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or "the Compan
Gainers Alector (NASDAQ:ALEC) shares increased by 9.7% to $2.59 during Tuesday's after-market s
Vivos Therapeutics, Inc. ("Vivos" or "the Company") (NASDAQ:VVOS), a leading medical
LITTLETON, Colo., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or “the Compan
Gainers Picard Medical (AMEX:PMI) stock rose 40.2% to $4.5 during Friday's after-market session
Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing
Vivos Therapeutics, Inc. (VVOS) came out with a quarterly loss of $0.31 per share versus the Zacks C
Vivos Therapeutics (NASDAQ:VVOS) held its second-quarter earnings conference call on Friday. Below i
Vivos Therapeutics, Inc. (VVOS) Q2 2026 Earnings Call Transcript
Quarter highlighted by steadily increasing patient demand for Vivos' differentiated array of highly
Vivos Therapeutics (NASDAQ:VVOS) reported quarterly losses of $(0.31) per share which beat the analy
LITTLETON, Colo., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Compan
Greenway analysis estimates AI-enabled automation in Nevada alone could create up to $9.0 million in
Greenway analysis estimates AI-enabled automation in Nevada alone could create up to $9.0 million in
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) stock increased by 107.0% to $2.65 during Wednesday'
LITTLETON, Colo., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or “the Compan
Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 43.0% to $1.43 during Wednesday&#
Arista Networks Inc (ANET) reported strong Q2 results, with revenue of $3.04B, up 37.7% YoY. Shares
Gainers Bluejay Diagnostics (NASDAQ:BJDX) stock moved upwards by 42.0% to $1.42 during Tuesday'
https://x.com/PatentGrants/status/2084730195765002647https://ppubs.uspto.gov/pubwebapp/external.html
Gainers Alzamend Neuro (NASDAQ:ALZN) stock increased by 12.9% to $1.35 during Tuesday's after-m
Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ:VVOS), a leading medical
LITTLETON, Colo., June 30, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Compan
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 40.3% to $4.56 during Tuesday's after-m
Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ:VVOS), a leading medical
Vivos and Streeterville Extend Timeframe of Financing Agreement and Reaffirm Commitment to Convert D
Key Terms of the Proposed Rights OfferingExercise price: Each right is expected to entitle the holde
LITTLETON, Colo., June 11, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Compan
Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ:VVOS), a leading medical
Vivos Announces Collaboration Agreement with Florida Cardiology Group to Extend Sleep Apnea and Inso
LITTLETON, Colo., June 08, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Compan
Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ:VVOS), a leading me
Vivos Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Stre
Ascendiant Capital analyst Lucas Ward maintains Vivos Therapeutics (NASDAQ:VVOS) with a Buy and r
Vivos Therapeutics, Inc. (VVOS) Q1 2026 Earnings Call Transcript
Vivos Therapeutics (NASDAQ:VVOS) reported quarterly losses of $(0.52) per share which missed the ana
Year-over-year revenue increased 70%, reflecting contribution from Vivos' acquisition of The Sleep C
Some of Wall Street's biggest upside calls are not sitting in the mega-cap names. They are hiding in
Wall Street analysts changed their outlook on top names. For all rating changes, see analyst ratings
Ascendiant Capital analyst Lucas Ward maintains Vivos Therapeutics (NASDAQ:VVOS) with a Buy and l